Allosteric effect of nanobody binding on ligand-specific active states of the β2 adrenergic receptor
Y Chen, O Fleetwood, S Pérez-Conesa… - Journal of Chemical …, 2021 - ACS Publications
Nanobody binding stabilizes G-protein-coupled receptors (GPCR) in a fully active state and
modulates their affinity for bound ligands. However, the atomic-level basis for this allosteric …
modulates their affinity for bound ligands. However, the atomic-level basis for this allosteric …
Allosteric effect of nanobody binding on ligand-specific active states of the β2-Adrenergic Receptor
Y Chen, O Fleetwood, S Pérez-Conesa, L Delemotte - bioRxiv, 2021 - biorxiv.org
Nanobody binding stabilizes the active state of G-protein-coupled receptor (GPCR) and
modulates its affinity for bound ligands. However, the atomic level basis for this allosteric …
modulates its affinity for bound ligands. However, the atomic level basis for this allosteric …
[PDF][PDF] Allosteric effect of nanobody binding on ligand-specific active states of the β2-Adrenergic Receptor
Y Chen, O Fleetwood, S Pérez-Conesa, L Delemotte - scholar.archive.org
Nanobody binding stabilizes the active state of G-protein-coupled receptor (GPCR) and
modulates its affinity for bound ligands. However, the atomic level basis for this allosteric …
modulates its affinity for bound ligands. However, the atomic level basis for this allosteric …
Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the beta 2 Adrenergic Receptor
Y Chen, O Fleetwood, S Perez-Conesa… - Journal of Chemical …, 2021 - diva-portal.org
Nanobody binding stabilizes G-protein-coupled receptors (GPCR) in a fully active state and
modulates their affinity for bound ligands. However, the atomic-level basis for this allosteric …
modulates their affinity for bound ligands. However, the atomic-level basis for this allosteric …
[HTML][HTML] Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
Y Chen, O Fleetwood, S Pérez-Conesa… - Journal of Chemical …, 2021 - ncbi.nlm.nih.gov
Nanobody binding stabilizes G-protein-coupled receptors (GPCR) in a fully active state and
modulates their affinity for bound ligands. However, the atomic-level basis for this allosteric …
modulates their affinity for bound ligands. However, the atomic-level basis for this allosteric …
Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
Y Chen, O Fleetwood… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Nanobody binding stabilizes G-protein-coupled receptors (GPCR) in a fully active state and
modulates their affinity for bound ligands. However, the atomic-level basis for this allosteric …
modulates their affinity for bound ligands. However, the atomic-level basis for this allosteric …
Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor.
Y Chen, O Fleetwood, S Pérez-Conesa… - Journal of Chemical …, 2021 - europepmc.org
Nanobody binding stabilizes G-protein-coupled receptors (GPCR) in a fully active state and
modulates their affinity for bound ligands. However, the atomic-level basis for this allosteric …
modulates their affinity for bound ligands. However, the atomic-level basis for this allosteric …
Allosteric effect of nanobody binding on ligand-specific active states of the β2-Adrenergic Receptor
Y Chen, O Fleetwood, S Pérez-Conesa, L Delemotte - 2021 - europepmc.org
Nanobody binding stabilizes the active state of G-protein-coupled receptor (GPCR) and
modulates its affinity for bound ligands. However, the atomic level basis for this allosteric …
modulates its affinity for bound ligands. However, the atomic level basis for this allosteric …